Travaux scientifiques

Doç. Dr. Barış Demirkol

74 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Hidden granulomatous-lymphocytic interstitial lung disease (GLILD): A missed diagnosis in granulomatous and interstitial lung diseases

    Tuberkuloz ve Toraks, 2026

    DOI 10.5578/tt.2026031189 Texte intégral en libre accèsSource : OpenAlex

  2. Autoantibody Positivity in Patients with Hypersensitivity Pneumonitis: A Subgroup Analysis of the TURK-HP Study Cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1967 Source : OpenAlex

  3. Antifibrotic Use in Hypersensitivity Pneumonitis: Real-World Data from a Subgroup Analysis of the TURK-HP Cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6288 Source : OpenAlex

  4. Regional Differences in Exposure Histories Among Patients Diagnosed with Hypersensitivity Pneumonitis: A Subgroup Analysis of TURK-HP Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6287 Source : OpenAlex

  5. Regional Variability in Diagnostic Approaches to Hypersensitivity Pneumonitis: Results From A National Multicenter Real-World Cohort (TURK-HP)

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6286 Source : OpenAlex

  6. Clinical, radiological and regional characteristics of hypersensitivity pneumonitis:The Turkish national cohort (TURK-HP study)

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6292 Source : OpenAlex

  7. Rare Interstitial Lung Diseases in the Elderly: A Different Spectrum?

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3089 Source : OpenAlex

  8. Real-world pulmonary phenotype and diagnostic pathways in Birt–Hogg–Dubé syndrome: a nationwide multicenter cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5276 Source : OpenAlex

  9. Comparison of Computed Tomography-Guided Transthoracic Core-Needle Biopsy and Fine-Needle Aspiration Biopsy Regarding Diagnostic Yield, Complications, and Molecular Testing Adequacy in Lung Cancer

    Brazilian Journal of Oncology, 2026

    DOI 10.1055/s-0046-1827828 Texte intégral en libre accèsSource : ORCID

  10. Survival Outcomes and Prognostic Determinants Across Histological Subtypes of Lung Adenocarcinoma: A Retrospective Analysis of 197 Cases

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1893 Source : OpenAlex

  11. Descriptive characteristics and prognostic factors in patients undergoing rigid bronchoscopy for malignant central airway obstruction

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6365 Source : OpenAlex

  12. Real-world effectiveness and safety of nintedanib in connective tissue disease– associated interstitial lung disease: Retrospective cohort study

    Tuberk Toraks, 2026

    DOI 10.5578/tt.2026031271 Texte intégral en libre accèsSource : ORCID

  13. Translation, Cultural Adaptation, and Validation of the Turkish Version of the St George's Respiratory Questionnaire for Idiopathic Pulmonary Fibrosis (SGRQ-I)

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-6-11 PMID 42902607 Texte intégral en libre accèsSource : Europe PMC

  14. Stepwise, precision-based management of allergic Bronchopulmonary Aspergillosis/Mycosis: A real-life multicenter study

    Allergologia et Immunopathologia, 2026

    DOI 10.15586/aei.v54i2.1623 PMID 41814613 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  15. The Role of Surgical Lung Biopsy in Diagnosis and Treatment Guidance for Interstitial Lung Diseases: A Single-Center Retrospective Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103956 PMID 42194917 Texte intégral en libre accèsSource : OpenAlex

  16. Efficacy and Safety of Broncho Muco Cleaner Balloon Dilation Therapy in Chronic Bronchitis-Predominant COPD: A Prospective Interventional Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15145607 PMID 42513520 Texte intégral en libre accèsSource : OpenAlex

  17. The Silent Gap in Diagnosis: First Analysis of Immunodeficiency Screening in Patients with Bronchiectasis in Turkey

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa702 Source : OpenAlex

  18. Prevalence and Prognostic Implications of Hiatal Hernia in Patients with Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3035 Source : OpenAlex

  19. Microbiological agents and antibiotic resistance patterns in stable and exacerbation periods of non-cystic fibrosis bronchiectasis: a multicentre study from Turkiye

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa754 Source : OpenAlex

  20. Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19

    Medical Principles and Practice, 2025

    DOI 10.1159/000543773 PMID 39870064 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  21. Does Mask Use During Activity Affect the Hemodynamic Response?

    Journal of Basic and Clinical Health Sciences, 2025

    DOI 10.30621/jbachs.1466683 Texte intégral en libre accèsSource : ORCID

  22. Interstitial Lung Disease Associated with Autoimmune Rheumatic Diseases: An Experience from Türkiye

    European Journal of Rheumatology, 2025

    DOI 10.5152/eurjrheum.2025.24117 PMID 40852743 Texte intégral en libre accèsSource : ORCID

  23. Sağlıklı Bireylerde İnspiratuar Kas Eğitiminin Kor Kas Kuvveti, Enduransı, Denge Üzerine Etkisi

    Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 2025

    DOI 10.46237/amusbfd.1480919 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  24. A Comment on ‘Screening for Obstructive Sleep Apnea Before Coronary Angiography’

    The Clinical Respiratory Journal, 2025

    DOI 10.1111/crj.70077 PMID 40223179 Texte intégral en libre accèsSource : ORCID

  25. Exercise-induced muscle oxygenation changes in fibrosing interstitial lung diseases: A near-infrared spectroscopy study

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025

    DOI 10.36141/svdld.v42i1.15942 PMID 40100111 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  26. Genomic Surveillance and Molecular Characterization of SARS-CoV-2 Variants During the Peak of the Pandemic in Türkiye

    Biochemical genetics, 2025

    DOI 10.1007/s10528-024-10962-8 PMID 39516327 Texte intégral en libre accèsSource : Europe PMC

  27. The clinical usefulness of neutrophil percentage/albumin ratio in predicting the one-month mortality in chronic obstructive pulmonary disease patients hospitalized with community-acquired pneumonia

    BMC Pulmonary Medicine, 2025

    DOI 10.1186/s12890-025-03757-z PMID 40490700 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  28. The impact of different pulmonary rehabilitation approaches on fibrotic interstitial lung disease: a comparative randomized trial

    Expert Review of Respiratory Medicine, 2025

    DOI 10.1080/17476348.2025.2513512 PMID 40440705 2 citations (OpenAlex) Source : OpenAlex

  29. Comparison of the effectiveness of pirfenidone and nintedanib in patients with advanced stage idiopathic pulmonary fibrosis.

    Sarcoidosis vasculitis and diffuse lung diseases, 2025

    DOI 10.36141/svdld.v42i3.16849 PMID 41026026 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  30. Clinical, Radiological, Functional Features, and Treatment Outcomes in Sporadic Lymphangioleiomyomatosis: An Observational Study

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa904 Source : OpenAlex

  31. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Systemic Inflammation Response Index in Predicting Mortality in Idiopathic Pulmonary Fibrosis: A 5-Year Real-World Study

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa5087 Source : OpenAlex

  32. Late Breaking Abstract - Efficacy and Safety of Broncho Muco Cleaner Balloon Dilatation Therapy in COPD

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa6200 Source : OpenAlex

  33. Comparison of Restaging Methods in Patients with Non-Small Cell Lung Cancer Receiving Neoadjuvant Therapy for N2 Disease

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa632 Source : OpenAlex

  34. The diagnostic contribution of bronchoalveolar lavage to lung cryo-transbronchial biopsy in interstitial lung diseases

    BMC Pulmonary Medicine, 2025

    DOI 10.1186/s12890-025-04059-0 PMID 41423605 Texte intégral en libre accèsSource : OpenAlex

  35. PD-L1 expression correlation with metabolic parameters of 18F-FDG PET/CT in nonsmall cell lung cancer,Corrélation de l'expression de PD-L1 avec les paramètres métaboliques du 18F-FDG TEP/TDM dans le cancer du poumon non à petites cellules

    Medecine Nucleaire, 2024

    DOI 10.1016/j.mednuc.2023.09.008 1 citation (OpenAlex) Source : ORCID

  36. Comparison of CT guided Transthoracic core needle Biopsy(CNB)and Fine Needle Aspiration(FNA)Biopsy in terms of Diagnostic value, complication and Samples Adequacy for Molecular testing in Lung Cancer.

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa5254 Source : OpenAlex

  37. A descriptive analysis of 21 patients with pulmonary amyloidosis: An observational study

    Medicine, 2024

    DOI 10.1097/md.0000000000040535 PMID 39533551 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  38. Bispectral index monitoring: Optimizing anesthesia in rigid bronchoscopy

    Tuberk Toraks, 2024

    DOI 10.5578/tt.202403938 PMID 39275931 Texte intégral en libre accèsSource : ORCID

  39. Synthesis and Characterization of Thymoquinone‐Oxime (TQ‐Ox) from Thymoquinone and Evaluation of its Cytotoxic, Genotoxic, and Apoptotic Potential in Lung Cancer Cells (A549) in vitro

    ChemistrySelect, 2024

    DOI 10.1002/slct.202304940 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  40. Role of quantitative planar lung perfusion scintigraphy and tomography in identifying target lobes in patients with emphysematous phenotype of advanced chronic obstructive pulmonary disease: a retrospective cross-sectional study

    Quantitative imaging in medicine and surgery, 2024

    DOI 10.21037/qims-24-125 PMID 39281166 Texte intégral en libre accèsSource : Europe PMC

  41. Investigation of respiratory muscle strength and its influence on exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis.

    Sarcoidosis vasculitis and diffuse lung diseases, 2024

    DOI 10.36141/svdld.v41i2.14884 PMID 38940715 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  42. Lung cancer in patients with pulmonary fibrosis: characteristics features and prognosis.

    Sarcoidosis vasculitis and diffuse lung diseases, 2024

    DOI 10.36141/svdld.v41i4.15675 PMID 39655590 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  43. Inhaled Aviptadil is a new hope for recovery of lung damage due to COVID-19

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa1506 Source : OpenAlex

  44. Efficacy and Safety of Broncho Muco Cleaner Balloon Dilatation Therapy in COPD(EXERTION®)

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa4352 Source : OpenAlex

  45. Clinicopathological features and prognostic factors in patients with pulmonary pleomorphic carcinoma

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa2418 Source : OpenAlex

  46. Does Muscle Oxygenation During The 6-Minute Walk Test in Fibrosing Lung Disease?

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa609 Source : OpenAlex

  47. Comparison of traditional and telerehabilitation based pulmonary rehabilitation program gains in fibrosing interstitial lung patients

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.oa3694 Source : OpenAlex

  48. A rare case: Endobronchial solitary mixed papilloma

    Tuberk Toraks, 2023

    DOI 10.5578/tt.20239712 PMID 37740634 Texte intégral en libre accèsSource : ORCID

  49. The Diagnostic Value of Procalcitonin in Differentiation of Exacerbation and Pneumonia in Patients with Idiopathic Pulmonary Fibrosis

    Hamidiye Medical Journal, 2023

    DOI 10.4274/hamidiyemedj.galenos.2023.24085 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  50. Cardiovascular risk assessment with pulse wave velocity, intima media thickness, and flow-mediated dilatation in patients with idiopathic pulmonary fibrosis

    Journal of Medicine and Palliative Care, 2023

    DOI 10.47582/jompac.1257975 Texte intégral en libre accèsSource : ORCID